Recovery from widowmaker heart surgery, which addresses blockages in the left anterior descending (LAD) artery, requires ...

This inflammation can cause cholesterol and other substances to collect along the site of the damage ... called a catheter ...

GII Innovation announced on the 20th that its board of directors has resolved to issue 11,644,800 shares through a ...

Most studies comparing coronary artery bypass graft patency are observational and opportunistic ... Second, the study was a large multicenter one, with graft data from >107 US sites. Most graft ...

The following is a summary of “Impact of frailty on outcomes following coronary artery bypass grafting: a systematic review ...

Hamad Medical Corporation's (HMC) Heart Hospital has expanded its use of surgical robots in coronary artery bypass grafting (Robotic CABG) surgeries. Robotic-assisted coronary artery bypass ...

XyloCor Therapeutics, Inc., ("XyloCor"), a clinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced the completion of a $67.5 million Series ...

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ...

Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year ...

This is known as coronary artery bypass grafting, also referred to as CABG (pronounced “cabbage”) or bypass surgery. In addition to relieving angina symptoms, another goal is to prevent a ...

XyloCor Therapeutics Inc., a Wayne gene therapy company, received $67.5 million from investors to support Phase 2 trials of a treatment designed to grow new blood vessels in the heart, XyloCor ...